Eye Ointments at CVS and Walmart Pulled Because of Infection Risk

Related media – Connected media

“The products are being recalled due to lack of sterility assurance at the facility noted during an inspection conducted by the Food and Drug Administration,” the announcement said. It added that, as of Feb. 16, the company had not received any reports of adverse reactions related to these products.

The products are intended to be sterile, the administrator said, because drugs applied to the eyes bypass some of the body’s natural defense systems.

Other eye products have been recalled in recent months.

In October, the F.D.A. advised consumers to stop using more than two dozen over-the-counter eyedrop products sold at stores including Target, CVS and Walmart after inspectors found unsanitary conditions at a manufacturing plant. Bacterial tests came back positive from critical drug production areas in the plant.

The manufacturer, Kilitch Healthcare, an Indian company also based in the state of Maharashtra, then voluntarily recalled the 27 eyedrop products. No adverse effects were reported at the time of the recall.

Early last year, the Centers for Disease Control and Prevention and the F.D.A. warned consumers to stop using two eyedrop products after they were tied to a drug-resistant bacteria strain found to have caused at least four deaths and vision loss in 14 patients.

Related media – Connected media
Anna Edwards

Recent Posts

Grand Theft Auto VI achieves record Metacritic score hours before launch

"Grand Theft Auto VI," Rockstar Games' first new mainline entry since "GTA V" in 2013,…

1 day ago

Nvidia posts $65.3 billion GAAP net income in Q3 2027, doubling previous year

Nvidia reported revenue of $115.8 billion for its third fiscal quarter of 2027, ended Oct.…

1 day ago

Cryo-electron microscopy reveals sensor activation in inflammasome assembly

A review by four immunologists at St. Jude Children's Research Hospital, published in Cell Research…

1 day ago

AI bubble could cause US recession before 2028, former SEC chair Gary Gensler says

The artificial intelligence boom is already a bubble that is likely to burst and push…

2 days ago

Deliverome uses AI to map the human cell surface and flags 1,108 candidate drug targets

More than 65% of approved medicines work by binding to proteins on the surface of…

2 days ago

How Experian’s RECLAIM documentary reveals the power of financial technology

Data and technology company Experian has released RECLAIM: Stories of Passion and Perseverance, a short…

3 days ago